BIO
Bio-Rad Laboratories Inc
381.00$
-1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.6% | 9.2% | 10.4% | 4.8% | 12.5% | 19.8% | 23.0% | 22.5% | 6.9% | 14.0% | 17.7% | 20.6% | |
| 6.9% | 6.5% | 6.9% | 6.9% | 6.0% | 5.8% | 5.4% | 4.6% | 4.9% | 5.5% | 5.9% | 6.4% | |
| 0.7% | 0.8% | 1.0% | 1.1% | 1.2% | 1.5% | 1.6% | 1.8% | 2.2% | 2.3% | 2.4% | 2.2% | |
| -0.1% | -0.2% | -0.1% | 1.7% | -12.9% | -87.9% | -135.8% | -129.2% | 187.5% | – | – | – | |
| 0.8% | -3.3% | -1.9% | -9.4% | 3.4% | 2.4% | 42.8% | 0.5% | -14.5% | -16.2% | -24.2% | 10.5% | |
| 6.3% | 5.6% | 6.8% | 5.3% | 5.7% | 4.3% | 4.3% | 4.1% | 4.1% | 5.9% | 7.4% | 6.1% | |
| -8.8% | -8.3% | -10.3% | -8.1% | -8.2% | -9.0% | -2.7% | -26.8% | -43.1% | 0.8% | -6.2% | -7.3% | |
| 0.0% | 0.0% | – | 0.2% | – | 165.7% | 0.8% | 1,207.2% | 2,433.2% | 3,747.3% | – | – | |
| 0.7% | 0.4% | 0.5% | -0.1% | -2.1% | -1.2% | -3.9% | -1.7% | -7.7% | -16.0% | -7.9% | -11.4% | |
| -0.1% | 0.0% | 0.0% | 0.0% | -0.1% | 0.0% | -16.8% | -0.1% | 42.3% | 0.0% | 0.0% | 0.0% | |
| 0.5% | 0.4% | 0.4% | 0.0% | -2.1% | -1.0% | -20.5% | -1.9% | 34.7% | -15.9% | -8.5% | -11.0% | |
| 3.8% | 2.2% | -0.1% | -3.3% | 2.1% | 9.9% | 0.2% | -6.7% | -1.3% | -1.1% | 3.3% | 1.6% | |
| 6.3% | 3.6% | 3.6% | -0.5% | 6.8% | 15.5% | 18.7% | 18.3% | 2.9% | 8.2% | 10.4% | 14.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.